Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication.
Hinterberger M, Endt K, Bathke B, Habjan M, Heiseke A, Schweneker M, Von Rohrscheidt J, Atay C, Chaplin P, Kalla M, Hausmann J, Schmittwolf C, Lauterbach H, Volkmann A, Hochrein H, Medina-Echeverz J.
Hinterberger M, et al. Among authors: chaplin p.
Sci Rep. 2023 Mar 30;13(1):5162. doi: 10.1038/s41598-023-32060-2.
Sci Rep. 2023.
PMID: 36997583
Free PMC article.